Losapotatab1 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 01)
Losartan Potassium Tablet, Film Coated
Product Images NDC 0904-7049
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 0904-7049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Losapotatab2 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 02)
This is a statistical report presenting the percentage of patients who achieved the primary endpoint in a clinical study comparing two medications, Atenolol and Losartan Potassium. The report also shows an adjusted risk reduction of 13% with a p-value of 0.021, suggesting that Losartan Potassium may be more effective than Atenolol in reducing the risk of the primary endpoint. The study was conducted over 66 months, with measurements taken at various time points from 18 to 66 months.*
Losapotatab3 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 03)
This is a statistical comparison of the efficacy of the drugs Atenolol and Losartan Potassium in preventing fatal/non-fatal stroke. The chart shows the percentage of patients in each group and an adjusted risk reduction of 25% with a p-value of 0.001. The other symbols and numbers seem to represent time intervals during the study.*
Losapotatab (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 04)
Losapotatab5 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 05)
This appears to be a table or graph displaying information related to the percentage of patients experiencing an event. Losartan Potassium Tablets are being compared to a placebo and it shows a risk reduction of 16.1% with a p-value of 0.022. However, without additional context or information, it is difficult to provide further details or a more comprehensive description.*
Carton Label (Image 01)
This is a product description for Losartan Potassium Tablets USP manufactured by Major. The NDC number is 0904-7047-61 and the package contains 100 tablets intended for unit dose dispensing. Each tablet has 25 mg of Losartan Potassium. The product is Rx only and the label has prescribing information, precautions, and warnings. The product is stored at a controlled room temperature of 20-25 °C (68-77 °F) and is for oral consumption.*
Carton Label (Image 02)
This is a medication package of Losartan Potassium tablets with NDC code 0904-7048-61. It contains individually packaged unit doses and must be dispensed by a pharmacist. Dosage instructions and a patient information sheet are not included in the package. The package should be kept at room temperature and in a light-resistant container.*
Carton Label (Image 03)
Losartan Potassium Tablets, USP with a dosage of 100mg per tablet are dispensed in unit doses by pharmacists. This product is prescribed for specific patients with information on dosage, precautions, and warnings. The container should be kept in a light-resistant container at room temperature and out of reach from children. The NDC number is 0904704961.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
